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Introduction
Invasive candidosis, especially catheter-related infections, 
still present major diagnostic and therapeutic challenges 
to the clinician.1,2 These infections are seen in patients in 
intensive care units,3 in immunocompromised hospital-
ized patients,4 and in patients with central venous cathe-
ters.5 The definite diagnosis of these infections is not only 
important from an epidemiological point of view, but the 
strains involved differ in their susceptibility to antifungal 
agents.6 Additionally, mixed infections caused by differ-
ent Candida species can be identified from the same 
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BACKGROUND/PURPOSE: Mixed infections caused by different Candida species are the rule rather 
than the exception. The discrimination between the two closely related species Candida albicans and Candida 
dubliniensis is not trivial. Therefore, there is a need for fast, reliable, and inexpensive methods with high 
specificity for the identification and differentiation of these two Candida species, which are frequently 
detected in the oral cavities of patients with a human immunodeficiency virus infection.
METHODS: We applied several phenotypic identification methods (growth on Rice-agar, Bird-seed agar, 
CHROMagar® Candida, API ID 32C; growth at 42ºC and 45ºC) and compared them with genotyping by 
arbitrarily primed-polymerase chain reaction.
RESULTS: A sensitivity of 44% for the identification of C. dubliniensis was achieved for growth on Rice-agar, 
97% for discrimination on Bird-seed agar, 95% with the assimilation profile index API ID 32C, and 97% when 
grown at 45ºC. We found two API codes not described for C. dubliniensis so far. Additionally, 88% of our 
C. dubliniensis isolates assimilated palatinose, in contrast to the 1% described in the API reference manual.
CONCLUSION: According to our results, cultivation of Candida isolates on Bird-seed agar after screen-
ing on CHROMagar® Candida is a very sensitive, simple, and cost-effective method for discriminating 
C. dubliniensis from C. albicans in routine practice.
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patient upon diagnosis of an infection7. Therefore, the 
need for fast, reliable and cost-effective methods with 
high specificity for the identification and differentiation 
of Candida species is of utmost importance.8–10
Candida dubliniensis has been detected in various clini-
cal samples, but mostly from specific risk groups such as 
human immunodeficiency virus (HIV)-infected indi-
viduals.11–15 The highest prevalence of C. dubliniensis was 
found in the oral cavity of HIV-infected individuals,11,16 in 
whom the rates varied between 17% and 25%.10,17 In con-
trast to these figures, the incidence of C. dubliniensis in the 
oral rinses of asymptomatic healthy individuals was 3%.18 
In addition, C. dubliniensis is rarely isolated from clinical 
samples such as bronchoalveolar lavage, sputum, vaginal, 
anal, and intestinal samples, from heart valves or from 
blood cultures in non-HIV-infected individuals.19–23
C. dubliniensis may be found in addition to other 
Candida species when isolated from an oral cavity.18,24 The 
increased clinical relevance of C. dubliniensis infection, 
and an unambiguous identification of this organism is 
still a problem. Using routine diagnostic methods such as 
the API ID 32C coding system, we frequently observed the 
assimilation of palatinose in our C. dubliniensis isolates. 
This is in contrast to the API ID 32C coding system for 
the identification of C. dubliniensis. Therefore, we exam-
ined a large group of molecularly identified C. dubliniensis 
and Candida albicans isolates for their assimilation charac-
teristics and compared the results with other phenotypic 
identification methods commonly used in routine myco-
logical laboratories.
Methods
Clinical specimens
All isolates were obtained from the oral cavity of HIV-
infected patients, who have a history of recurrent oropha-
ryngeal candidosis. The patients were asked to clean their 
mouth with tap water before rinsing their oral cavity with 
10 mL sterile isotonic sodium chloride solution. From each 
sample, 100 μL were plated onto Sabouraud-Dextrose-Agar 
or CHROMagar® Candida for further diagnostic work-up.
Media and reference strains
Rice-agar and Bird-seed agar were purchased as ready to 
go plates (Heipha, Eppelheim, Germany). The ingredients 
for Sabouraud-Dextrose-Agar (DIFCO Laboratories, Detroit, 
MI, USA) and CHROMagar® Candida (Mast Diagnostica, 
Reinfeld, Germany) were purchased and prepared accord-
ing to the manufacturer’s instructions. C. albicans ATTC 
90028 and C. dubliniensis CBS 8500 were used as reference 
strains for all experiments.
Cultivation on CHROMagar® Candida
All clinical specimens were analyzed by parallel cultivation 
on 2% Sabouraud-Dextrose agar, and on CHROMagar® 
Candida. The plates were incubated at 37ºC for 2 days, 
and for 1 additional day at room temperature, before they 
were examined. The colonies were identified according to 
their shade of green. The dark green was used as a poten-
tial indicator for C. dubliniensis, whereas C. albicans colonies 
developed a light green appearance. 18,25–27 All green colo-
nies were analyzed by arbitrarily primed-polymerase chain 
reaction (AP-PCR), which served as the reference method 
for discrimination of C. dubliniensis from other Candida 
species, C. albicans in particular.
AP-PCR
AP-PCR was originally described by Welsh and McClelland 
and uses one primer with an arbitrary sequence.28 The 
amplification in a PCR yields a band pattern that is spe-
cific for the corresponding template DNA, able to differ-
entiate between different species, and is therefore used 
as the reference method. In our experiments, the RP02 
primer described by Akopyanz et al, which has the se-
quence 5-GCG ATC CCC A-3, was used.29 The use of this 
primer in an AP-PCR for the characterization of C. dub-
liniensis was reported by Sullivan et al.16 The PCR was set 
up in a final volume of 50 μL, with 100 ng template DNA. 
The cycling conditions were as follows: 5 minutes at 94ºC, 
5 minutes at 36ºC, and 5 minutes at 72ºC for 4 cycles; fol-
lowed by 30 cycles of 1 minute at 94ºC, 1 minute at 36ºC 
and 2 minutes at 72ºC, and a final extension at 72ºC for 
10 minutes. PCR products (7 μL) were loaded on a 1.2% 
agarose gel containing ethidium bromide and the band 
patterns were documented with a digital camera.
Carbohydrate assimilation assay (API ID 32C)
The API ID 32C assay was performed according to the 
manufacturer’s recommendations (AB bioMérieux, Marcy-
l’Etoile, France). Reading was performed visually after 
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incubating the plates for 24–72 hours at 29ºC. For test 
interpretation, the software api-web™ 2006 (AB bioMer-
ieux) was used.
Rice-agar
One colony was transferred onto a Rice-agar plate and 
incubated under reduced oxygen tension (a cover slip was 
put on top of the smeared cells) for 24–72 hours at room 
temperature. The colonies were then inspected micro-
scopically. Under these growth conditions, C. dubliniensis 
produced many thick-walled chlamydospores at the end 
of short branched pseudohyphae, which appeared fre-
quently as duplets, triplets, or in larger groups.23
Bird-seed agar (Cryptococcus Agar according to Staib)
One colony was transferred from Sabouraud-Dextrose 
agar onto Bird-seed agar and incubated at 30ºC in the 
dark. The growth of C. dubliniensis was characterized mi-
croscopically by rough colony morphology, caused by 
pseudomycelia and chlamydospores, which could be eas-
ily differentiated from C. albicans cells that form smooth 
colonies after a 2-day cultivation on this agar as described 
previously.30
Growth at increased temperature
Yeast cells were plated onto Sabouraud-Dextrose-agar 
plates and incubated at 42ºC and 45ºC according to the 
protocol of Pinjon et al.31 The plates were examined after 
24 hours and 48 hours.
Results
The yeast isolates from oral samples were grown on differ-
ent types of growth media (summarized in Table 1). From 
these isolates, 111 were identified as C. dubliniensis by AP-
PCR. To calculate the specificity of the tests, we also 
analyzed 107 C. albicans isolates, which were tested with 
all methods. Interestingly, we also identified 48 non-
C. albicans/non-C. dubliniensis isolates from the oral rinses, 
including 30 C. glabrata, 10 C. krusei, 3 C. tropicalis, 2 C. lam-
bica, and 3 Saccharomyces cerevisiae (data not shown). 
Almost half of the C. dubliniensis isolates (48/111) were 
isolated from mixed cultures, together with up to three 
other Candida species. Since our main focus was the 
differentiation between C. dubliniensis and C. albicans, all 
other non-C. albicans and non-C. dubliniensis isolates were 
spared.
Species identification with AP-PCR
All green colonies grown on CHROMagar® Candida were 
subjected to the AP-PCR analysis. The banding patterns 
for all strains were reproducible and distinct from each 
other for all species (Figure). A total of 111 isolates were 
identified as C. dubliniensis and 107 isolates were identified 
as C. albicans. All Candida isolates were studied with the 
test methods listed above. Additionally, all C. dubliniensis 
isolates were later hybridized with the species specific 
Cd25 probe,32 and these results confirmed our AP-PCR 
studies (data not shown).
Table 1. Summary of the data for cultivation methods used for the identification of C. dubliniensisa. The cultivation on Bird-seed 
agar, the API ID 32C method, and the incubation at 45ºC demonstrate a high sensitivity and specificity for the identification of 
both species. While the majority of the C. dubliniensis isolates grew at 42ºC (resulting in the poor sensitivity of 3%), only the 
strongly restricted growth of C. dubliniensis in comparison to C. albicans at 45ºC (i.e. 97% sensitivity) is able to differentiate between 
the two Candida species
Cultivation method C. dubliniensis–Sensitivity (n = 111) C. albicans–Specificity (n = 107)
CHROMagar® Candida  14 (13) 102 (95)
Rice agar  49 (44) 104 (97)
Bird-seed agar 108 (97) 105 (98)
Growth at 42ºC 108 (97) 107 (100)
Growth at 45ºC  3 (3) 107 (100)
API ID 32C 106 (95) 106 (99)
aData presented as n (%).
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Strain identification with API ID 32C assay
The following API ID 32C codes were detected: 
7142.1400.15, 7142.1000.15, 7143.1400.15, 7042.1000.15, 
and 7142.1400.11. Of the 111 isolates identified as C. dub-
liniensis by AP-PCR, 104 revealed an API ID 32C code 
which had been described for this species, but seven iso-
lates showed an API ID 32C code which identified the iso-
lates as C. albicans. The API ID 32C code 7142.1400.15 was 
found in 92 C. dubliniensis isolates, code 7142.1000.15 in 
11 isolates, code 7147.3400.15 in five isolates, code 
7147.1400.15 in two isolates, and code 7042.1000.15 in 
one isolate. Interestingly API ID 32C code 7147.3400.15 
and API ID 32C code 7147.1400.15, found in seven 
C. dubliniensis isolates, had previously been described for 
C. albicans.
All C. dubliniensis isolates assimilated D-galactose, 
actidione (cycloheximide) D-maltose, D-saccharose, po-
tassium 2-ketogluconate, D-sorbitol, D-mannitol and 
D-glucose, while none of the isolates was able to assimi-
late L-arabinose, D-cellobiose, D-raffinose, D-ribose, L-
rhamnose, erythritol, D-melibiose, sodium-glucuronate, 
D-melezitose, potassium-gluconate, levulinate, D-lactose, 
inositol or L-sorbose. Eighty-eight percent of our C. dub-
liniensis isolates assimilated palatinose, which is in con-
trast to only 1% as described in the API database. The 
sensitivity of the method was 95%. One of the 107 C. albi-
cans isolates showed an API ID 32C code which refers to 
C. dubliniensis. The results of all API ID 32C tests are sum-
marized in Table 2.
CHROMagar® Candida
Of 111 colonies picked from CHROMagar® Candida, 14 
isolates were dark green (i.e. C. dubliniensis). This leads to a 
test sensitivity of 12.6%. From the 107 isolates identified 
as C. albicans by AP-PCR, 102 yielded colonies with a 
lighter shade of green (i.e. C. albicans).
Rice-agar results
All of the 111 isolates produced pseudomycelia and 
chlamydospores on rice-agar, but only 49/111 isolates 
showed a set of features characteristic for C. dubliniensis. 
These features included an exceedingly high number of 
chlamydospores, many branched and short pseudomyce-
lia, and chlamydospores which were grouped in duplets 
or triplets. The sensitivity of this method for the identifi-
cation of C. dubliniensis was 44.1%.
Cultivation on Bird-seed agar
Of the 111 isolates identified as C. dubliniensis according 
to AP-PCR, 108 demonstrated rough colonies on Bird-
seed agar, leading to an assay sensitivity of 97.3%. Of the 
107 C. albicans isolates tested, 105 showed colonies with 
smooth edges, leading to a test specificity of 98.1%.
Growth at elevated temperatures
Of the 111 C. dubliniensis isolates, 108 grew at 42ºC and 3 
grew at 45ºC, which corresponds to a test sensitivity of 3% 
(growth at 42ºC) and 97% (growth at 45ºC). All 107 C. al-
bicans isolates grew at both temperatures.
Discussion
The development of a fast, specific, and sensitive method 
for the identification of Candida species is crucial for 
accurate mycological diagnosis and therapy. In addition, 
the method should be inexpensive and easy to use for ap-
plication in routine laboratories. The cultivation of yeasts 
on solid growth media, and its phenotypic characteriza-
tion, is easy to perform and frequently the method of 
choice.
Growth on special agar plates, such as CHROMagar® 
Candida, is a very useful tool for the determination of 
bp
2176
M 1 2 3 4 5 6 7 8 9 M
1766
1230
1033
653
517
453
394
298
234
220
Figure. Species discrimination with arbitrarily primed-polymerase 
chain reaction. M = Molecular weight marker VI, Roche Applied 
Science (154–2176 bp, the 220 bp and 234 bp bands can not be 
discriminated); 1 = C. albicans ATCC 90028; 2 = C. dubliniensis CD 
36; 3 = C. dubliniensis CBS 8500; 4 = C. dubliniensis CBS 8501; 5 = C. 
glabrata DSM 90050; 6 = C. parapsilosis; 7 = C. krusei; 8 = C. kefyr 
DSM 11954; 9 = C. albicans ATCC 76615.
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whether clinical isolates grow as monocultures, or in 
mixed cultures.24 Our observation that 48/111 of the 
C. dubliniensis clinical isolates obtained from oral samples 
of HIV-infected individuals grew as mixed cultures under-
scores this fact. Interestingly, in our samples, C. dublinien-
sis was most frequently associated with C. glabrata (25%) 
and not with C. albicans as described before.18,24 About 75% 
of our patients were either continuously, or temporarily, 
exposed to fluconazole, which could have led to the se-
lection of C. glabrata, which is less sensitive to azole 
antimycotics.
The aim of this paper was to identify the most specific 
conventional phenotypic method from a panel of com-
monly used testing systems that could yield comparable 
results as a genotyping tool for the discrimination of the 
closely related species C. albicans and C. dubliniensis. In our 
Table 2. Comparison of data obtained with the API ID 32C assay with the API® database from AB bioMerieux, France
 Assimilation (%)
Carbohydrate source Present study API® database
 C. dubliniensis C. albicans C. dubliniensis C. albicans
D-Galactose 100 100 100 98
Actidione (Cycloheximide) 100 100 100 99
D-Saccharose 100 100 100 100
N-Acetyl-Glucosamine 99.5 100 90 100
Lactic acid 0.5 3.6 10 96
L-Arabinose 0 0 0 0
D-Cellobiose 0 0 0 0
D-Raffinose 0 0 0 1
D-Maltose 100 100 100 100
D-Trehalosea 6.6 100 0 97
Potassium 2-Ketogluconate 100 100 100 100
Methyl-αD-Glucopyranosidea 6.1 98.6 0 98
D-Sorbitol 100 100 100 99
D-Xylosea 4.7 97.1 0 98
D-Ribose 0 0 0 1
Glycerol 0.5 0 0 10
L-Rhamnose 0 0 0 0
Palatinoseb 88.2 100 1 100
Erythritol 0 0 0 0
D-Melibiose 0 0 0 0
Sodium-Glucuronate 0 0 0 0
D-Melezitose 0 0 0 0
Potassium-Gluconate 0 0 0 2
Levulinate 0 0 0 1
D-Mannitol 100 100 100 100
D-Lactose 0 0 0 1
Inositol 0 0 0 1
D-Glucose 100 100 100 98
L-Sorbose 0 0 0 0
Glucosamine 99.5 100 60 99
aBest suited for the identification of C. dubliniensis; ba new observation.
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study, all green colonies grown on CHROMagar® Candida 
were identified to be either C. albicans or C. dubliniensis. 
However, in contrast to other studies demonstrating that 
it is possible to use this method for a differentiation 
between these two species,33 we found that the assay yields 
a low sensitivity for the discrimination between C. dub-
liniensis and C. albicans. The shade of green (either light or 
dark) could not reliably discriminate between the two 
Candida species.34–38 In addition, the incubation tempera-
ture has an influence on the results obtained with this 
assay,39 and C. dubliniensis isolates which are revived after 
storage at low temperatures (−20ºC or less) can lose their 
ability to form dark green colonies, and develop a light 
green color only.24 We used this assay as a screening tool 
to differentiate between C. albicans plus C. dubliniensis (as 
one group) and other Candida spp., and obtained a specifi-
city of 100% (data not shown).
Another chromogenic medium, Candida ID2, has 
been successfully used for the detection of mixed cultures, 
and led to the differentiation between C. dubliniensis and 
C. albicans with very good sensitivity and specificity.40 
Sahand et al mixed CHROMagar® Candida with Pal’s 
medium,36 and observed that the two species could be eas-
ily differentiated from each other according to the color 
and colony morphology.
In addition to chromogenic media, there are several agar 
plate cultivation methods described, discriminating between 
C. dubliniensis and C. albicans due to abundant chlamydospore 
formation of the former species. In contrast, C. albicans 
produces fewer chlamydospores at the end of pseudo-
hyphae under these growth conditions.16,23,30,41,42 Our 
results demonstrate that the colony morphology of cells 
grown on Bird-seed agar is not only a useful method for 
the identification of C. dubliniensis, but shows the high-
est sensitivity and specificity of all the agar cultivation 
methods. In addition, cultivation on Bird-seed agar is easy 
to perform.
We observed a high test sensitivity for the differentia-
tion between the two species when the cells were grown at 
45ºC, but not when they were grown at 42ºC, which is in 
contrast to others who demonstrated highly restricted 
growth, or no growth at all, when C. dubliniensis was incu-
bated at 42ºC.31,43 According to these conflicting results, 
the discrimination of C. dubliniensis from C. albicans by 
growth at increased temperature may not be reliable. Also, 
the method used for growth at increased temperatures re-
quires additional equipment.
The identification of C. dubliniensis with the API ID 32C 
system is seen as a specific and sensitive assay, and one of 
its advantages is the ease of the determination, i.e. 
the appearance of turbidity in the cultivation vessels.44 If 
the identification of C. dubliniensis depends on a single 
assimilation reaction, the time at which the results are 
determined is of crucial importance. It is known that the 
API ID 32C code 7143.1400.15, which identifies C. dub-
liniensis, develops after a cultivation period of 48 hours 
and, therefore, we determined all API ID 32C codes after 
this time. In our study, 104/111 C. dubliniensis isolates 
identified by AP-PCR showed an API ID 32C code which 
had been published before.11,16,26 Interestingly, we also 
detected seven C. dubliniensis isolates showing two differ-
ent API ID 32C codes, which have been associated with 
C. albicans. The most striking observation is the assimila-
tion of palatinose in 88% of our C. dubliniensis isolates, in 
contrast to the 1% described in the API reference manual. 
Our observation is in agreement with data obtained by 
Sullivan et al in a small number of isolates.16 The assimi-
lation data for trehalose, methyl-αD-glucopyranoside 
and xylose show the largest differences between C. dub-
liniensis and C. albicans and, therefore, a panel of these car-
bohydrates seems to be best for the differentiation of 
these species. In contrast, Tintelnot et al concluded that 
the observed pattern for the assimilation of xylose, lactic 
acid and methyl-αD-glucopyranoside is not able to dis-
criminate between C. dubliniensis and C. albicans.43 Pincus 
et al found that lactic acid, methyl-αD-glucopyranoside, 
xylose, and trehalose are the best assimilation markers for 
discrimination between C. dubliniensis and C. albicancs,26 
but assimilation of lactic acid by the majority of C. dub-
liniensis isolates had also been described.24,43 We observed 
that methyl-αD-glucopyranoside and xylose are assimi-
lated by 6.1% and 4.7%, respectively, of our C. dubliniensis 
isolates, while others reports show that none of these iso-
lates were able to metabolize these carbohydrates.12,16,26,45 
An even higher percentage of cells able to assimilate xy-
lose (up to 57%) has also been described.24,43,46 While, in 
some reports, the discriminatory power of the API ID 32C 
assay was described as poor,37,38,45 our results suggest that 
the specificity of the API ID 32C method is rather high, and 
useful for the reliable identification of C. dubliniensis.47
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A useful extension of the available methods for the 
identification of C. dubliniensis might be the recently devel-
oped antibody based latex agglutination test,48–50 but 
apart from the higher costs of this assay, there are so far 
not enough data available about how this method per-
forms in the routine laboratory.
In summary, we conclude that using the Bird-seed agar 
method after screening on chromogenic agars such as 
CHROMagar® Candida for green colonies is a very sensi-
tive, simple and cost-effective method to discriminate 
C. dubliniensis from C. albicans in routine practice. Other 
phenotypic identification methods do not add further 
relevant discriminative information, or should be used in 
special cases only.
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